Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 16/20 | 0.49 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.46 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17559324 | 0.81 | GPR119 (0.48) | ACACBGPR119 | |
| SCHEMBL23057533 | 0.80 | ACACB (0.49) | ACACBGPR119 | |
| SCHEMBL22152251 | 0.80 | GPR119 (0.49) | GPR119 | |
| SCHEMBL23044953 | 0.77 | GPR119 (0.47) | ACACBGPR119 | |
| SCHEMBL28939074 | 0.76 | GPR119 (0.52) | GPR119 | |
| SCHEMBL20000617 | 0.74 | ACACB (0.48) | ACACBGPR119 | |
| SCHEMBL30932113 | 0.74 | ACACB (0.48) | ACACBGPR119 | |
| SCHEMBL389972 | 0.73 | ACACB (0.43) | ACACBGPR119 | |
| SCHEMBL389971 | 0.73 | ACACB (0.43) | ACACBGPR119 | |
| SCHEMBL390047 | 0.73 | ACACB (0.43) | ACACBGPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112409333-B | Phenylpyrrolidine compounds | 武汉人福创新药物研发中心有限公司 | 2024-06-14 | — | — | CN | disclosed |
| WO-2021036953-A1 | PHENYLPYRROLIDINE COMPOUND | 湖北生物医药产业技术研究院有限公司 | 2021-03-04 | — | — | WO | disclosed |
| WO-2021036953-A1 | PHENYLPYRROLIDINE COMPOUND | 湖北生物医药产业技术研究院有限公司 | 2021-03-04 | — | — | WO | disclosed |
| CN-112409333-A | Phenylpyrrolidines | 湖北生物医药产业技术研究院有限公司 | 2021-02-26 | — | — | CN | disclosed |